MedNet Announces “2015 Feature 1” Release of iMedNet eClinical

Enhancements Target Risk-Based Monitoring, Randomization, Inventory, Coding and Adjudication.

Minnetonka, MNMedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is pleased to announce that the latest release of its iMedNet eClinical technology platform will be made available to all iMedNet customers by the end of this month.  iMedNet is an award-winning, cloud-based and fully “unified” eClinical system – built from the ground up by MedNet Solutions’ own internal development team based on the company’s extensive 15 year track record delivering proven eClinical technologies.  iMedNet’s built-in ease-of-use, flexibility and affordability make it ideal for any type of research initiative anywhere around the world.

“Our 2015 Feature 1 Release provides many innovative new capabilities that focus on making clinical research more efficient than ever,” remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions.  “We’re especially excited about our new configurable, algorithm-driven Risk-Based Monitoring module, and the substantial enhancements we’ve made to streamline randomization and inventory management activities.  In addition, iMedNet now makes MedDRA and WHO Drug auto coding even easier, simplifies enrollment and data entry controls, and streamlines the CEC adjudication process.”

MedNet will be providing a “sneak peek” of the iMedNet 2015 Feature 1 release at its booth at the Drug Information Association (DIA) Annual Meeting in Washington DC, June 15-17, 2015.  For more information, or to set up a demonstration of iMedNet for your organization, please contact MedNet Solutions.